Work

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

Year: 2004

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.20776

Authors: David A. Reardon, Jennifer A. Quinn, James Vredenburgh, Jeremy N. Rich, Sridharan Gururangan, Michael Badruddoja, James E. Herndon, Jeannette M. Dowell, Allan H. Friedman, Henry S. Friedman

Institution: Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Center for Research Resources

Awards: G460175554, G488511823, G4946238614, SRC on Primary Tumors of the CNS, SPORE in Brain Cancer

OpenAlex ID: W2011192975

FWCI: 5.765

Cites: 61

Cited by: 116

Related to: 10